SEC Filing Summary: Wayside Technology Group, Inc. (WSTG)
Business Context and Reporting Period
This Form 8-K was filed on July 28, 2022, by Wayside Technology Group, Inc. (WSTG), a Delaware corporation listed on the NASDAQ Global Market. The report addresses a significant corporate governance event occurring on July 23, 2022, and the subsequent regulatory implications.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific event and does not contain financial statement data.
Material Changes
- Board Composition: The Board of Directors was reduced to six members following the passing of Mr. Ross Crane, an independent director who joined in December 2019.
- Committee Structure: The Audit Committee was reduced to two members. Mr. Crane served as the Chair of the Audit Committee and was a member of the Nominating and Corporate Governance Committee.
- Regulatory Compliance: Due to the reduction in Audit Committee members, the Company is no longer compliant with Nasdaq Listing Rule 5605(c)(2), which requires a minimum of three members on the Audit Committee.
Outlook, Risks, and Management Commentary
Management expressed condolences to Mr. Crane's family and acknowledged his dedication. The Company notified Nasdaq of the non-compliance on July 28, 2022. The Company intends to take actions to satisfy the Listing Rules prior to the expiration of the cure period, which is the earlier of the next annual stockholders meeting or July 23, 2023. The primary risk identified is the potential delisting or failure to satisfy continued listing standards if the cure period is not met.
Investor Verification Checklist
- Verify the timeline for appointing a new independent director to restore the Audit Committee to three members.
- Monitor subsequent filings for confirmation of compliance with Nasdaq Listing Rule 5605(c)(2) before July 23, 2023.
- Review the Company's next annual stockholders meeting schedule to determine if it precedes the July 2023 cure deadline.